Carlos Fernandez de Larrea, MD, PhD from the Hospital Clínic de Barcelona, Barcelona, Spain discusses which techniques can be used to establish disease response in multiple myeloma (MM). For the detection of minimal residual disease (MRD), the most established technique is flow cytometry. In terms of imagng, clear criteria for the evaulation of PET/CT are required. Dr de Larrea further discussses the importance of standardizing the various techniques.
Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.